Abbvie Inc
Change company Symbol lookup
Select an option...
ABBV Abbvie Inc
SFDMY Shanghai Fudan Microelectronics Group Co Ltd
PTNR Partner Communications Company Ltd
CHPT ChargePoint Holdings Inc
BASMX iShares Total U.S. Stock Market Index Fund Investor A Shares
FLNT Fluent Inc
CCXI ChemoCentryx Inc
NVTA Invitae Corp
CLNE Clean Energy Fuels Corp
IMBBY Imperial Brands PLC
Go

Health Care : Biotechnology | Large Cap Value
Company profile

AbbVie Inc. (AbbVie) is a research-based biopharmaceutical company. The Company is engaged in research and development, manufacturing, commercialization and sale of medicines and therapies. AbbVie offers its products in various therapeutic categories, including Immunology products, which include Humira, Skyrizi and Rinvoq; Oncology products consists of Imbruvica and Venclexta; Aesthetics products include Botox Cosmetic, Juvederm Collection and other aesthetics; Neuroscience products, such as Botox Therapeutic, Vraylar, Duopa and Duodopa, and Ubrelvy; Eye care products consists of Lumigan, Alphagan and Restasis ; Women's health products include Lo Loestrin, Orilissa and other women's health; and Other key products, which includes Mavyret, Creon, Lupron, Linzess and Synthroid. The Company's products are sold worldwide directly to wholesalers, distributors, government agencies, health care facilities and independent retailers from AbbVie-owned distribution centers and public warehouses.

Closing Price
$140.34
Day's Change
2.30 (1.67%)
Bid
--
Ask
--
B/A Size
--
Day's High
140.80
Day's Low
137.77
Volume
(Light)
Volume:
4,854,572

10-day average volume:
6,725,942
4,854,572
  • Prev Close
    138.04
  • Today's Open
    138.04
  • Day's Range
    137.77-140.80
  • Avg Vol (10-day)
    6.7M
  • Last (time)
    7:00p ET 08/08/22
  • Last (size)
    1
  • 52-Wk Range
    105.56 - 175.91
    LowHigh
  • (09/20/21 - 04/08/22)
    32.95%
  • 21.7%
  • Market Cap
    248.1B
  • Shares Outstanding
    1.8B
  • 7.07
  • 19.52x
  • $5.64/4.09%
  • Ex-dividend Date
    07/14/22
  • Dividend Pay Date
    08/15/22
  • 0.7
  • 68.63
  • (% of float 07/15/22)
    0.79

Latest News

August 08, 2022
4:33 pm ET
MarketWatch
August 06, 2022
10:17 am ET
MarketWatch
August 05, 2022
4:33 pm ET
MarketWatch
August 04, 2022
4:33 pm ET
MarketWatch
August 03, 2022
4:33 pm ET
MarketWatch
August 02, 2022
4:33 pm ET
MarketWatch
August 01, 2022
10:25 pm ET
Globe Newswire
4:33 pm ET
MarketWatch
July 29, 2022
10:50 pm ET
PR Newswire
4:33 pm ET
MarketWatch
8:17 am ET
MarketWatch
7:46 am ET
MarketWatch
7:45 am ET
MarketWatch
7:44 am ET
MarketWatch
7:43 am ET
MarketWatch
7:43 am ET
MarketWatch
7:43 am ET
MarketWatch
July 28, 2022
4:33 pm ET
MarketWatch
July 27, 2022
4:33 pm ET
MarketWatch
July 26, 2022
4:33 pm ET
MarketWatch
July 25, 2022
4:33 pm ET
MarketWatch
8:00 am ET
PR Newswire
July 22, 2022
4:33 pm ET
MarketWatch
July 21, 2022
4:33 pm ET
MarketWatch
July 20, 2022
4:33 pm ET
MarketWatch
July 18, 2022
10:05 am ET
BusinessWire
2:00 am ET
PR Newswire
July 15, 2022
10:50 pm ET
BusinessWire
4:33 pm ET
MarketWatch
July 14, 2022
4:33 pm ET
MarketWatch
July 13, 2022
4:33 pm ET
MarketWatch
July 12, 2022
4:34 pm ET
MarketWatch
July 11, 2022
4:33 pm ET
MarketWatch
July 08, 2022
4:33 pm ET
MarketWatch
8:00 am ET
PR Newswire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.